Thereby, pSS patients could be stratified in interferon negative, Type I or Type I + II positive subgroups with higher prevalence of anti-SSA and anti-SSB among those with IFN activation without relation with systemic activity. Here, IFNA1 is linked to peeling skin syndrome.